Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

Uber (UBER) reported upbeat Q1 results, including gross bookings that were up 19% year-over-year [read more]
Pfizer (PFE) reported better-than-expected Q1 earnings and revenue and reiterated its FY23 outlook [read more]
IBM (IBM) CEO Arvind Krishna told Bloomberg in an interview that the company will slow down or stop back-office hiring given a view that staff may be replaced by AI and automation [read more]
Marriott (MAR) provided a "beat and raise" report for Q1 [read more]
The Writers Guild of America is going on strike after studio talks fail [read more]

2. WALL STREET CALLS:

Morgan Stanley upgraded Dell Technologies (DELL) to Overweight and HP Inc. (HPQ) to Equal Weight as the firm contends that the worst of the PC downcycle is likely in the past [read more]
Chegg (CHGG) was downgraded at Barrington, Northland and Jefferies after earnings as artificial intelligence headwinds are "starting to impact the fundamental story" [read more]
Quest Diagnostics (DGX) downgraded to Neutral from Buy at BofA [read more]
Wedbush downgraded SoFi Technologies (SOFI) to Neutral, lowered its price target to $5 [read more]
Citi downgraded Coinbase (COIN) to Neutral on regulatory uncertainty [read more]

3. AROUND THE WEB:

Disney (DIS) sued by appointed board for control of park’s expansion, NY Times report [read more]
UnitedHealth (UNH) loses legal battle against KKR’s (KKR) Envision Healthcare, FT says [read more]
Microsoft (MSFT) testing private alternative to ChatGPT, The Information reports [read more]
Morgan Stanley (MS) preparing 3,000 more layoffs, Bloomberg reports [read more]
Tesla (TSLA) is increasing prices in the U.S., Canada, Japan, and China, Reuters reports [read more]

4. MOVERS:

Thoughtworks (TWKS) jumps after Bloomberg reported an Apax-led consortium is weighing a buyout of the company [read more]
Immatics (IMTX) gains after reporting interim clinical data from ongoing Phase 1b dose expansion Cohort A treated with ACTengine IMA203 TCR-T monotherapy [read more]
Icahn Enterprises (IEP) came under pressure following a Hindenburg short report [read more]
Community Health (CYH) slides after reporting quarterly results [read more]
Travere Therapeutics (TVTX) falls after its sparsentan study failed to meet its primary efficacy endpoints [read more]

5. EARNINGS/GUIDANCE:

Nautilus (NLS) reported preliminary Q4 results and raised its FY23 guidance [read more]
Harmony Biosciences (HRMY) Q1 revenue and EPS beat consensus and CEO Jeffrey Dayno said he was “pleased to report another quarter of strong performance” [read more]
Repligen (RGEN) delivered Q1 results and lowered its FY23 revenue and EPS guidance [read more]
Sealed Air (SEE) reported Q1 EPS and revenue that missed consensus [read more]
California Resources (CRC) provided Q1 results and CEO Francisco Leon said the company is “off to a great start this year” [read more]

INDEXES:

The Dow fell 367.17, or 1.08%, to 33,684.53, the Nasdaq lost 132.09, or 1.08%, to 12,080.51, and the S&P 500 declined 48.29, or 1.16%, to 4,119.58.